Related references
Note: Only part of the references are listed.Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α
Ivan D. Mascanfroni et al.
NATURE MEDICINE (2015)
Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
Xing Li et al.
TUMOR BIOLOGY (2015)
Polymorphisms of vascular endothelial growth factor on prognosis in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization treatment
J. Song et al.
GENETICS AND MOLECULAR RESEARCH (2014)
Hepatocellular carcinoma: clinical frontiers and perspectives
Jordi Bruix et al.
GUT (2014)
Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer
Krasimira Aleksandrova et al.
HEPATOLOGY (2014)
Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma
Bulent Cetin et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Hepatic Venous Congestion in Living Donor Grafts in Liver Transplantation: Is There an Effect on Hepatocellular Carcinoma Recurrence?
Suk-Won Suh et al.
LIVER TRANSPLANTATION (2014)
Single measurement of hemoglobin predicts outcome of HCC patients
Fabian Finkelmeier et al.
MEDICAL ONCOLOGY (2014)
Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma
Xing Li et al.
TUMOR BIOLOGY (2014)
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival
Marco Biolato et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials
Xing Li et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2013)
Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study
Mauro Borzio et al.
FUTURE ONCOLOGY (2013)
Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
Mei-Hsuan Lee et al.
HEPATOLOGY (2013)
Postprogression Survival of Patients With Advanced Hepatocellular Carcinoma: Rationale for Second-Line Trial Design
Maria Reig et al.
HEPATOLOGY (2013)
Prognosis of Patients with Hepatocellular Carcinoma Treated Solely with Transcatheter Arterial Chemoembolization: Risk Factors for One-year Recurrence and Two-year Mortality (Preliminary Data)
Michitaka Matsuda et al.
INTERNAL MEDICINE (2013)
Long-term surgical outcomes of cervical dumbbell neurinomas
Masaya Nakamura et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2013)
Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results
Omer Basar et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Association Between Insulin-like Growth Factor-2 Expression and Prognosis after Transcatheter Arterial Chemoembolization and Octreotide in Patients with Hepatocellar Carcinoma
Zheng-Ping Xiong et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma
M. Grimm et al.
MEDICAL ONCOLOGY (2012)
A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma
Hiraku Yodono et al.
ANTI-CANCER DRUGS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Loco-Regional Treatment of Hepatocellular Carcinoma
Riccardo Lencioni
HEPATOLOGY (2010)
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
M Kudo et al.
JOURNAL OF GASTROENTEROLOGY (2003)